Complement C3: an emerging risk factor in cardiometabolic disease
Open Access
- 27 January 2012
- journal article
- editorial
- Published by Springer Science and Business Media LLC in Diabetologia
- Vol. 55 (4), 881-884
- https://doi.org/10.1007/s00125-012-2462-z
Abstract
C3 is the central component of the complement system and activation of C3 via any of the three major activation pathways—the classical, the lectin and the alternative pathways—results in initiation of the terminal complement pathway and release of the anaphylatoxin C3a. Both terminal pathway activation and signalling of C3a and its inactivation product C3a-desarg via the C3a receptor and C5a-like receptor 2, respectively, can induce inflammatory, immunomodulatory and metabolic responses. C3 has been implicated in metabolic disorders, notably adiposity, dyslipidaemia, insulin resistance, liver dysfunction and diabetes, and C3 is increasingly recognised as a cardiometabolic risk factor. C3 may play a role in the macrovascular, as well as microvascular, complications of diabetes. Moreover, C3 may interact with the coagulation system and as such also contribute to a procoagulant, hypofibrinolytic and, ultimately, prothrombotic state. Recent data suggest a diabetes-dependent incorporation of C3 into fibrin clots, with concomitant effects on clot characteristics. Taken together, epidemiological and experimental evidence concordantly point to a role of complement C3 in metabolic, atherosclerotic/atherothrombotic and microangiopathic processes and further research should be directed towards the elucidation of complement function and activation in cardiometabolic disorders.This publication has 26 references indexed in Scilit:
- Interactions between coagulation and complement—their role in inflammationSeminars in Immunopathology, 2011
- Complement C3 and cleavage products in cardiometabolic riskClinica Chimica Acta; International Journal of Clinical Chemistry, 2011
- Complement in atherosclerosis: friend or foe?Journal of Thrombosis and Haemostasis, 2011
- Complement Factor H Is Expressed in Adipose Tissue in Association With Insulin ResistanceDiabetes, 2009
- The C3a Anaphylatoxin Receptor Is a Key Mediator of Insulin Resistance and Functions by Modulating Adipose Tissue Macrophage Infiltration and ActivationDiabetes, 2009
- Local complement activation triggers neutrophil recruitment to the site of thrombus formation in acute myocardial infarctionThrombosis and Haemostasis, 2009
- Palmitate and oleate induction of acylation stimulating protein resistance in 3T3-L1 adipocytes and preadipocytesJournal of Cellular Biochemistry, 2007
- The Role of Complement in Inflammatory Diseases From Behind the Scenes into the SpotlightThe American Journal of Pathology, 2007
- Serum C3 Is a Stronger Inflammatory Marker of Insulin Resistance Than C-Reactive Protein, Leukocyte Count, and Erythrocyte Sedimentation RateDiabetes Care, 2007
- Reduced adipose tissue triglyceride synthesis and increased muscle fatty acid oxidation in C5L2 knockout miceJournal of Endocrinology, 2007